Considering this, many tumor hyperexpressed enzymes but with low concentrations in healthy tissues, such as matrix metalloproteinases and cathepsins, offer the possibility of enzyme-responsive drug delivery systems [164]. This evidence concerns the gene CTSS and neoplasm.